116 related articles for article (PubMed ID: 24582564)
1. Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells.
Dong Y; Pan Q; Jiang L; Chen Z; Zhang F; Liu Y; Xing H; Shi M; Li J; Li X; Zhu Y; Chen Y; Bruce IC; Jin J; Ma X
Biochem Biophys Res Commun; 2014 Mar; 446(1):85-90. PubMed ID: 24582564
[TBL] [Abstract][Full Text] [Related]
2. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells.
Ma X; Cai Y; He D; Zou C; Zhang P; Lo CY; Xu Z; Chan FL; Yu S; Chen Y; Zhu R; Lei J; Jin J; Yao X
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16282-7. PubMed ID: 22988121
[TBL] [Abstract][Full Text] [Related]
3. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance.
Ma X; Chen Z; Hua D; He D; Wang L; Zhang P; Wang J; Cai Y; Gao C; Zhang X; Zhang F; Wang T; Hong T; Jin L; Qi X; Chen S; Gu X; Yang D; Pan Q; Zhu Y; Chen Y; Chen D; Jiang L; Han X; Zhang Y; Jin J; Yao X
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6389-94. PubMed ID: 24733904
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
5. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.
Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X
Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
7. A methylation-based regulatory network for microRNA 320a in chemoresistant breast cancer.
He DX; Gu XT; Jiang L; Jin J; Ma X
Mol Pharmacol; 2014 Nov; 86(5):536-47. PubMed ID: 25159093
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
9. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of vascular endothelial growth factor release in long-term drug-treated breast cancer via transient receptor potential channel 5-Ca(2+)-hypoxia-inducible factor 1α pathway.
Zhu Y; Pan Q; Meng H; Jiang Y; Mao A; Wang T; Hua D; Yao X; Jin J; Ma X
Pharmacol Res; 2015 Mar; 93():36-42. PubMed ID: 25579062
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
Tran TP; Kim HG; Choi JH; Na MK; Jeong HG
Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342
[TBL] [Abstract][Full Text] [Related]
12. Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance.
Zhang FF; Zhu YF; Zhao QN; Yang DT; Dong YP; Jiang L; Xing WX; Li XY; Xing H; Shi M; Chen Y; Bruce IC; Jin J; Ma X
Eur J Pharmacol; 2014 Sep; 738():83-90. PubMed ID: 24877693
[TBL] [Abstract][Full Text] [Related]
13. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
14. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
[TBL] [Abstract][Full Text] [Related]
15. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its functional characterization.
Shen Y; Chu Y; Yang Y; Wang Z
Oncol Rep; 2012 May; 27(5):1535-40. PubMed ID: 22307172
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
18. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil.
Zhang L; Yang Y; Wei XY; Shi YR; Liu HY; Niu RF; Hao XS
J Exp Clin Cancer Res; 2007 Jun; 26(2):201-7. PubMed ID: 17725099
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Treatment with Gadopentetic Acid or Gadodiamide Increases TRPC5 Expression and Decreases Adriamycin Nuclear Accumulation in Breast Cancer Cells.
Zhang W; Wang M; Lv W; White FA; Chen X; Obukhov AG
Cells; 2023 May; 12(9):. PubMed ID: 37174704
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
